![Samuel Agresta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Agresta
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/05/2026
Profilo
Samuel Agresta is Chief Medical Officer at OnKure Therapeutics, Inc. since 2024.
Former positions include Senior Medical Director at Genentech, Inc. from 2007 to 2010; Senior Medical Director at Merrimack Pharmaceuticals, Inc. from 2010 to 2011; Director at Infinity Pharmaceuticals, Inc. from 2019 to 2023; Associate Medical Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc. from 2004 to 2010; Vice President & Head-Clinical Development at Agios Pharmaceuticals, Inc. from 2011 to 2018; and Chief Medical Officer at Foghorn Therapeutics, Inc. from 2019 to 2023.
Education includes graduate studies at the University of South Florida, an undergraduate degree from Georgetown University in 1994, a doctorate from Tulane University School of Medicine, and graduate studies at Tulane University School of Public Health & Tropical Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Samuel Agresta
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Samuel Agresta
| Società | Posizione | Fine |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 11/09/2023 |
| INFINITY PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 16/10/2019 |
| AGIOS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2018 |
| MERRIMACK PHARMACEUTICALS | Direttore Tecnico/Scientifico/R&S | 01/12/2011 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Direttore Tecnico/Scientifico/R&S | 01/12/2010 |
Formazione di Samuel Agresta
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
88
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Commercial Services |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University School of Public Health & Tropical Medicine
 Tulane University School of Public Health & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
